Results 131 to 140 of about 1,107,385 (201)

Clinical CYP2D6-Mediated Pharmacokinetic Drug-Drug Interactions of DA-8010 with Paroxetine or Mirabegron in Healthy Korean Participants. [PDF]

Drug Des Devel Ther
Ryu H, Cho JY, Lee DY, Lee S.
europepmc   +1 more source

Progress of coproporphyrin as an endogenous biomarker for transporter-mediated drug-drug interactions. [PDF]

Front Pharmacol
Zhao P, Hu Y, Hu X, Xu Y, Jiang B, Lou H.   +5 more
europepmc   +1 more source

The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens. [PDF]

Transl Clin Pharmacol
Stankeviciute S, Tsai A, Rayad N, Kruse M.   +3 more
europepmc   +1 more source

Population Pharmacokinetic Model Assessment of the Effects of Body Weight on Risk of Drug-Drug Interactions After Posaconazole Discontinuation. [PDF]

Clin Transl Sci
Wrishko RE, Bateman TJ, Johnson MG, Kothare PA.   +3 more
europepmc   +1 more source

Extracting drug-drug interactions from biomedical texts

BMC Bioinformatics, 2010
de Pablo-Sánchez César, Martínez Paloma, Segura-Bedmar Isabel   +2 more
doaj   +1 more source

Physiologically-Based Pharmacokinetics of Ribociclib Drug-Drug Interactions and Organ Impairment Pharmacokinetics in Early Breast Cancer. [PDF]

Pharmaceuticals (Basel)
Ji Y, Huth F, Wang C, Schiller H, Combes FP, Crown J, Fasching PA, Zarate JP, Untch M.   +8 more
europepmc   +1 more source

Impact of Complex Genetic and Drug-Drug Interactions on Tamoxifen Metabolism and Efficacy. [PDF]

J Pers Med
Saad I, Bentayebi K, Ettoury S, Zarrik O, Bourais I, Boutayeb S, Samer C, Daali Y, Eljaoudi R, Louati S.   +9 more
europepmc   +1 more source

Etoposide dosing challenges in a testicular cancer patient with hepatic impairment and drug-drug interactions-a case report. [PDF]

Cancer Chemother Pharmacol
Op 't Hoog CJP, de Jong LAW, Sijm J, Smits M, Mulder SF, Boerrigter E.   +5 more
europepmc   +1 more source

Potential drug-drug interactions in hospitalized patients with acute coronary syndrome at a tertiary care hospital in upper Egypt. [PDF]

Front Pharmacol
Ghabesha AA, Hassan SB, Hasan-Ali H, Abdel-Latif MMM.   +3 more
europepmc   +1 more source

Predicting drug-drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling. [PDF]

Front Mol Biosci
Ribeiro GSG, Paranhos BAPB, Dörr F, Yonamine M, Villanova B, Guerra LTL, Raminelli AO, Reis JAS, de Paula CC, Zacharias ABV, Cecílio Hallak JE, Dos Santos RG, Martins FS, Marcourakis T.   +13 more
europepmc   +1 more source